latest update:
[TrialBase DB]

trial summary · NCT07746427

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Outcomes of a Digital Mindfulness Meditation App-Based Intervention in Adolescents With Moderate to Severe Atopic Dermatitis (MIND-AD)

Trial record from the TrialBase DB dataset, status RECRUITING, condition Atopic Dermatitis, sponsored by Weill Medical College of Cornell University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07746427phase —enrollment 40start 2026-11-15

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.

Source record: https://clinicaltrials.gov/study/NCT07746427

Facts

registry idNCT07746427
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionAtopic Dermatitis
sponsorWeill Medical College of Cornell University
sponsor classOTHER
enrollment40
start date2026-11-15
primary completion2028-07
completion2028-07
results postednot reported

Conditions

  • Atopic Dermatitis
  • Eczema

Interventions

  • Digital App Mindfulness Meditation
  • Mindfulness Meditation Sheet

Countries

  • United States

Intervention types: BEHAVIORAL

Work with this record